Diagnostic Utility of p63, Ck5/6 and ER in Papillary Neoplasms of Breast
Indus Journal of Bioscience Research · 30.05.2025 · 3 (5) · 1239-1245
DOI: 10.70749/ijbr.v3i5.2974 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indus Journal of Bioscience Research, online erschienen am 30.05.2025. Verfasst von Anum Rashid und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Papillary neoplasms of breast consist of broad spectrum of lesions ranging from intraductal papilloma to papilloma with ADH/DCIS, papillary DCIS, encapsulated papillary carcinoma, solid papillary carcinoma(insitu/invasive) and invasive papillary carcinoma. It is very challenging to classify these lesions as benign or malignant as they have similar papillary architecture. The classification as benign or malignant depends on the presence or absence of myoepithelial layer and epithelial atypia. Various myoepithelial and epithelial markers are used for this purpose. However, certain markers are more specific and helpful than others. In this study, we are evaluating the diagnostic utility of myoepithelial markers (p63 and CK5/6) and epithelial marker (ER) in the various papillary lesions, so the timely diagnosis and early management can be done in better way. Material and Methods: In this study, we determine the expression of myoepithelial immunohistochemical markers (p63 and ck5/6) and epithelial marker (ER) in benign and malignant papillary lesions of breast (201 cases) constituting of intraductal papilloma (142 cases), papillary DCIS (5 cases), encapsulated papillary carcinoma (15 cases), solid papillary carcinoma in situ (6 cases), invasive solid papillary carcinoma (15 cases) and invasive papillary carcinoma (15 cases).
Results
Ck5/6 shows 99%, p63 shows 98.51% and ER shows 99% diagnostic accuracy in all the cases of intraductal papillomas. P63 shows 100% diagnostic accuracy in invasive solid papillary carcinoma while in other atypical and malignant lesions it shows 99.50% diagnostic accuracy. Ck5/6 shows 100% diagnostic accuracy in papillary DCIS, invasive solid and invasive papillary carcinoma, 99.50% in encapsulated papillary carcinoma and 99% in solid papillary carcinoma insitu. While ER has 100% diagnostic accuracy in papillary DCIS and solid carcinoma in situ, 99.50% in encapsulated papillary carcinoma, 99% in invasive papillary carcinoma and 94.4% in invasive solid papillary carcinoma.
Conclusion
Combined panel of myoepithelial and epithelial immunohistochemical markers is required to differentiate various benign and malignant papillary lesions with diagnostic accuracy, timely diagnosis and early treatment.
Zitieren
APA
Rashid, A., Syed, F. R. A., & Chughtai, A. S. (2025). Diagnostic Utility of p63, Ck5/6 and ER in Papillary Neoplasms of Breast. Indus Journal of Bioscience Research, 3(5), 1239-1245. https://doi.org/10.70749/ijbr.v3i5.2974
Vancouver
Rashid A, Syed FRA, Chughtai AS. Diagnostic Utility of p63, Ck5/6 and ER in Papillary Neoplasms of Breast. Indus Journal of Bioscience Research. 2025;3(5):1239-1245. doi:10.70749/ijbr.v3i5.2974
BibTeX
@article{Rashid2025,
author = {Rashid, Anum and Syed, Fatima Rooman Ali and Chughtai, Akhter Sohail},
title = {Diagnostic Utility of p63, Ck5/6 and ER in Papillary Neoplasms of Breast},
journal = {Indus Journal of Bioscience Research},
year = {2025},
volume = {3},
number = {5},
pages = {1239--1245},
doi = {10.70749/ijbr.v3i5.2974}
}
EUVIMED